Injectable Diclofenac for the Prevention of Post-operative Dental Pain

Phase 2 Completed 75 enrolled IBSA Institut Biochimique SA

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a prospective, randomised, double-blind, placebo-controlled, parallel group study in approximately 75 patients undergoing surgical removal of an impacted lower third molar.

Timeline

Start: 2013-01
Primary completion: 2013-05
Completion: 2013-05

Publications

Gorecki P, Rainsford KD, Taneja P, Bulsara Y, Pearson D, Saund D, Ahmed B, Dietrich T. Submucosal Diclofenac for Acute Postoperative Pain in Third Molar Surgery: A Randomized, Controlled Clinical Trial. J Dent Res. 2018 Apr;97(4):381-387. doi: 10.1177/0022034517744207. Epub 2017 Dec 4.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Diclofenac	Other / unclassified	5 mg/ml	Other
Subject	Diclofenac	Other / unclassified	12.5 mg/ml	Other
Subject	Diclofenac	Other / unclassified	25 mg/ml	Other
Subject	Diclofenac	Other / unclassified	50 mg/ml	Other

Indications

No indication recorded.